Previous close | 0.8772 |
Open | 0.8700 |
Bid | 0.8375 x 100 |
Ask | 0.9205 x 100 |
Day's range | 0.8610 - 0.8806 |
52-week range | 0.8600 - 4.3700 |
Volume | |
Avg. volume | 102,172 |
Market cap | 12.671M |
Beta (5Y monthly) | 1.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Microbot Medical (MBOT) files an IDE with the FDA, approval of which will enable the company to proceed with its human clinical study in the United States.
Microbot Medical's (MBOT) latest favorable study results are likely to support its IDE submission to the FDA to commence its human clinical study.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...